ArticleNature reviews. Rheumatology2022
Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET.
Abstract readPublished Erratum
In one paragraph
Article in Nature reviews. Rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025.Orphanet journal of rare diseases · 2026Review
Corrections and comments
- Erratum for
Authors and funding
57 authors.
Rosaria TalaricoRheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Silvia AguileraSpanish Association for Antiphospholipid Syndrome (SAF España), Elche, Spain.
Tobias AlexanderDepartment of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-1193-0097
Zahir AmouraDepartment of Internal Medicine, Hospital Pitié-Salpêtrière, Assistance Publique Hôpitaux de Paris, French National Referral Center for SLE and APS, Paris, France.
Ana M AntunesAuto-immune Disease Unit, Hospital de Curry Cabral, Centro Hospitalar de Lisboa Central, EPE, Lisbon, Portugal.
Laurent ArnaudService de rhumatologie, Hôpitaux Universitaires de Strasbourg, Centre National de Référence des Maladies Systémiques et Auto-immunes Rares Grand-Est Sud-Ouest (RESO), Strasbourg, France.ORCID http://orcid.org/0000-0002-8077-8394
Tadej AvcinDepartment of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Lorenzo BerettaReferral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
Stefano BombardieriUniversity of Pisa, Pisa, Italy.
Gerd R BurmesterDepartment of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany.
Sara CannizzoRheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Lorenzo CavagnaDepartment of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Benjamin ChaigneService de Médecine Interne, Hôpital Cochin, Centre de Référence Maladies systémiques Autoimmunes Rares d'Ile de France, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
Alain CornetLupus Europe, Brussels, Belgium.
Nathalie Costedoat-ChalumeauService de Médecine Interne, Hôpital Cochin, Centre de Référence Maladies systémiques Autoimmunes Rares d'Ile de France, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
Andrea DoriaRheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.
Alessandro FerrarisMedical Genetics Laboratory, Molecular Medicine Department, San Camillo Forlanini Hospital, Sapienza University, Rome, Italy.
Rebecca Fischer-BetzDepartment of Rheumatology, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
João E FonsecaRheumatology Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.
Charissa FrankFlemish Association for Hereditary Connective Tissue Disorders, Koersel, Belgium.
Andrea GagliotiRheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Ilaria GalettiFederation of European Scleroderma Associations (FESCA), Milan, Italy.
Jürgen GrunertDeutsche Ehlers-Danlos Initiative e.V., Furth, Germany.
Vera GuimarãesLiga Portuguesa Contra as Doenças Reumáticas, Lisbon, Portugal.
Eric HachullaDépartement de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Systémiques et Auto-Immunes Rares du Nord-Ouest (CERAINO), LIRIC, INSERM, Univ. Lille, CHU Lille, Lille, France.
Frederic HoussiauDepartment of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Luca IaccarinoRheumatology Unit, Department of Medicine, University of Padova, Padova, Italy.
Thomas KriegDepartment of Dermatology, Universitätsklinikum, Cologne, Germany.
Marteen LimperDepartment of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Fransiska MalfaitCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.ORCID http://orcid.org/0000-0002-5010-0304
Xavier MarietteUniversité Paris-Saclay, INSERM, CEA, Centre de recherche en Immunologie des infections virales et des maladies auto-immunes; AP-HP. Université Paris-Saclay, Hôpital Bicêtre, Rheumatology Department, Le Kremlin Bicêtre, Paris, France.
Diana MarinelloRheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.ORCID http://orcid.org/0000-0002-5537-6043
Thierry MartinClinical immunology department, Hôpitaux Universitaires de Strasbourg, Centre National de Référence des Maladies Systémiques et Auto-immunes Rares Grand-Est Sud-Ouest (RESO), Strasbourg, France.
Lisa MatthewsRelapsing Polychondritis Awareness and Support, Worcester, UK.
Marco Matucci-CerinicDivision of Rheumatology and Scleroderma Unit, Department of Clinical and Experimental Medicine, AOU Careggi, University of Florence, Florence, Italy.
Alain MeyerService de rhumatologie, Hôpitaux Universitaires de Strasbourg, Centre National de Référence des Maladies Systémiques et Auto-immunes Rares Grand-Est Sud-Ouest (RESO), Strasbourg, France.
Carlomaurizio MontecuccoDepartment of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Luc MouthonService de Médecine Interne, Hôpital Cochin, Centre de Référence Maladies systémiques Autoimmunes Rares d'Ile de France, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
Ulf Müller-LadnerDepartment of Rheumatology and Clinical Immunology, Kerckhoff Klinik, Justus Liebig University of Giessen, Bad Nauheim, Germany.
Simona RednicDepartment of Rheumatology, Emergency County Teaching Hospital, Cluj-Napoca, Romania.
Vasco C RomãoRheumatology Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.
Matthias SchneiderDepartment of Rheumatology, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Vanessa SmithDepartment of Rheumatology, Ghent University Hospital Department of Internal Medicine, Ghent, Belgium.
Alberto SulliResearch Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS Polyclinic Hospital San Martino, University of Genoa, Genoa, Italy.
Farah TamirouDepartment of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Domenica TaruscioNational Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Anna V TaulaigoAuto-immune Disease Unit, Hospital de Curry Cabral, Centro Hospitalar de Lisboa Central, EPE, Lisbon, Portugal.
Enrique TerolDirectorate-General for Health and Food Safety, European Commission, Brussels, Belgium.
Angela TincaniRheumatology and Clinical Immunology Unit, ASST-Spedali Civili and University of Brescia, Brescia, Italy.
Simone TicciatiRheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Giuseppe TurchettiInstitute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
P Martin van HagenDepartment of Internal Medicine and Immunology, Erasmus MC, Rotterdam, Netherlands.
Jacob M van LaarDepartment of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Ana VieiraLiga Portuguesa Contra as Doenças Reumáticas, Núcleo Síndrome de Sjögren, Lisbon, Portugal.
Jeska K de Vries-BouwstraDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Maurizio CutoloResearch Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS Polyclinic Hospital San Martino, University of Genoa, Genoa, Italy.
Marta MoscaRheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy. ern.reconnet@ao-pisa.toscana.it.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.